Pharmaceutical composition for prevention and treatment of motion sickness syndrome
US6028198A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Apr 19, 1996 |
| Grant date | Feb 22, 2000 |
| Priority date | — |
| Expiry date | Apr 19, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/439
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention involves a pharmaceutical composition for preventing and treating motion sickness syndrome, the method of using it to treat motion sickness syndrome and the method for preparing phencynonate hydrochloride of .alpha.-configuration, the active component of the pharmaceutical composition. As compared with the known anti-motion sickness drugs, the pharmaceutical composition of the present invention showed higher efficacy and lower side effects. In addition, the pharmaceutical composition of the present invention can also be used for preventing and treating many symptoms of functional disorders of central and peripheral cholinergic system resulting from excessive central and peripheral acetyl choline.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.